Page 87 - Registration Document News Today

PRESS RELEASERegulated information Paris, 4 November 2022, 6 pm Availability of the third amendment to the 2022 Universal Registration Document Societe...

PRESS RELEASERegulated information Paris, 4 November 2022, 6 pm Availability of the third amendment to the 2022 Universal Registration Document Societe Generale hereby informs the public that the... | November 4, 2022

04.11.2022 - PRESS RELEASERegulated information Paris, 4 November 2022, 6 pm Availability of the third amendment to the 2022 Universal Registration Document Societe Generale hereby informs the public that the third amendment to the 2022 Universal Registration ...

Regulatory News: Advicenne (Euronext Growth Paris ALDVI FR0013296746) (Paris:ALDVI), a specialty pharmaceutical company dedicated to developing and commercializing innovative treatments for those

PARIS--(BUSINESS WIRE)--Regulatory News:Advicenne (Euronext Growth Paris ALDVI - FR0013296746) (Paris:ALDVI), a specialty pharmaceutical company dedicated to developing and commercializing innovative treatments for those suffering from rare renal diseases, today announces today its participation in two major interna...

Dynamic monitoring of the intestinal barrier with Confocal Laser Endomicroscopy demonstrated to be far superior to endoscopic and histologic biomarkers as predictors of long-term remission Intestinal

Continued growth at a steady pace Revenue for Q3 2022: €1,216.9 million, equating to total growth of 9.0% and organic growth of 7.7% Organic revenue growth for the first 9 months of the

Investegate announcements from Airbus SE, Airbus reports Nine-Month (9m) 2022 results

EQS-Ad-hoc: Airbus SE / Key word(s): Quarter Results Airbus SE: Airbus reports Nine-Month (9m) 2022 results 28-Oct-2022 / 06:29 CET/CEST Disclosure of an inside information acc. to Article 17 MAR

Investegate announcements from Natwest Markets PLC, Publication of Supplementary Prospectus